ImmunityBio's total assets for Q2 2026 were $628.50M, a decrease of -2.80% from the previous quarter. DE:26CA total liabilities were $1.67B for the fiscal quarter, a 10.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.